Abstract
Scopolamine reversed the reduction in avoidance responding caused by spiperone and antagonized the inhibitory effects of spiperone on the behavioral actions of d-amphetamine or apomorphine. Scopolamine-induced locomotor activity was greater in 6-hydroxydopamine (6-OHDA)-treated animals than in controls. This increase was prevented by administration of α-methyltyrosine, but not by inhibition of dopamine-β-hydroxylase, indicating that this action of scopolamine was associated with presynaptic dopaminergic fibers. Therefore, the possibility that pre-synaptic dopaminergic function was the locus of the antagonism of spiperone by scopolamine was examined using drug interaction studies in 6-OHDA-treated rats. However, when 6-OHDA-treated rats were given α-methyltyrosine, scopolamine still reversed the spiperone blockade of apomorphine-induced locomotion. Although these data provided evidence for a post-synaptic action for this cholinergic blocking agent, scopolamine affected neither dopamine-stimulated adenylate cyclase activity nor 3H-spiperone binding in vitro. Furthermore, scopolamine did not alter the level of specific 3H-spiperone binding found in brain after in vivo administration. This suggests that the postsynaptic mechanism affected by scopolamine is different from the site affected by spiperone. Thus, it is concluded that scopolamine can affect both pre- or post-synaptic events associated with dopaminergic function and that both may contribute to the reversal of the actions of spiperone.
Similar content being viewed by others
References
Ahlenius S, Engel J (1971) Behavioral effects of haloperidol after tyrosine hydroxylase inhibition. Eur J Pharmacol 15:187–192
Andén NE, Bédard P (1971) Influence of cholinergic mechanisms on the function and turnover of brain dopamine. J Pharm Pharmacol 23:460–462
Arnfred T, Randrup A (1968) Cholinergic mechanism in brain inhibiting amphetamine-induced stereotyped behavior. Acta Pharmacol Toxicol (Kbh) 26:384–394
Bowers MB, Roth RH (1972) Interaction of atropine-like drugs with dopamine-containing neurones in rat brain. Br J Pharmacol 44:301–306
Breese GR, Cooper BR, Smith RD (1973) Biochemical and behavioral alterations following 6-hydroxydopamine administration into brain. In: Usdin E, Snyder S (eds) Frontiers in catecholamine research. New York, Pergamon Press, pp 701–706
Breese GR, Traylor TD (1971) Depletion of brain noradrenaline and dopamine by 6-hydroxydopamine. Br J Pharmacol 42:88–99
Breese GR, Traylor TD (1970) Effect of 6-hydroxydopamine on brain norepinephrine and dopamine: evidence for selective degeneration of catecholamine neurons. J Pharmacol Exp Ther 174:413–420
Brune GG, Morpurgo C, Bielkus A, Kobayashi T, Tourlentes TT, Himwich HE (1962) Relevance of drug-induced extrapyramidal reactions to behavioral changes during neuroleptic treatment. Treatment with trifluoperazine singly and in combination with trihexyphenidyl. Compr Psychiatry 3:227–234
Cheney DL, Costa E (1978) Biochemical pharmacology of cholinergic neurons. In: Lipton MA, Di Mascio A, Killam KF (eds) Psychopharmacology: A generation of progress. New York, Raven Press, pp 283–291
Cooper BR, Breese GR, Grant LD, Howard JL (1973) Effects of 6-hydroxydopamine treatments on active avoidance responding: evidence for involvement of brain dopamine. J Pharmacol Exp Ther 185:358–370
Costall B, Hui SCG, Naylor RJ (1979) Hyperactivity induced by injection of dopamine into the accumbens nucleus: actions and interactions of neuroleptic cholinomimetic and cholinolytic agents. Neuropharmacology 18:661–665
Coyle JT, Snyder SH (1969) Antiparkinsonian drugs: inhibition of dopamine uptake in the corpus striatum as a possible mechanism of action. Science 166:899–901
de Belleroche J, Luamani Y, Bradford HF (1979) Evidence for presynaptic cholinergic receptors on dopaminergic terminals: degeneration studies with 6-hydroxydopamine. Neuroscience Lett 11:209–213
Duvoisin RC (1967) Cholinergic-anticholinergic antagonism in Parkinsonism. Arch Neurol 17:124–136
Fuxe K, Agnati LF, Hökfelt T, Lidbrink P, Ljungdahl A, Löfström A, Ungerstedt U (1975) The effect of dopamine receptor stimulating and blocking agents on the activity of supersensitive dopamine receptors and on the amine turnover in various dopamine nerve terminal systems in the rat brain. J Pharmacol 6:117–129
Gianutsos G, Lal H (1976) Alteration in the action of cholinergic and anticholinergic drugs after chronic haloperidol: indirect evidence for cholinergic hyposensitivity. Life Sci 18:515–520
Haase H-J, Janssen PAJ (1965) The action of neuroleptic drugs. Amsterdam, North Holland
Hanson HM, Stone CA, Witoslawki JJ (1970) Antagonism of the antiavoidance effects of various agents by anticholinergic drugs. J Pharmacol Exp Ther 173:117–124
Hollister AS, Breese GR, Cooper BR (1974) Comparison of tyrosine hydroxylase and dopamine-β-hydroxylase inhibition with the effects of various 6-hydroxydopamine treatments on d-amphetamine induced locomotor activity. Psychopharmacologia 36:1–16
Höllt V, Czlonkowski A, Herz A (1977) The demonstration in vivo of specific binding sites for neuroleptic drugs in mouse brain. Brain Res 130:176–183
Iversen LL (1975) Dopamine receptors in the brain. Science 188:1084–1089
Janowsky DS, El-Yousef MK, Davis JN, Sekerke HJ (1972) Cholinergic antagonism of methylphenidate-induced stereotyped behavior. Psychopharmacologia 27:295–303
Kelly PH, Seviour PW, Iversen SD (1975) Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum. Brain Res 94:507–522
Kilbey MM, Ellinwood EH Jr (1977) Chronic administration of stimulant drugs: response modification. In: Ellinwood EH, Kilbey MM (eds) Cocaine and other stimulants. Adv. in behavioral biology, Vol 21. Plenum Press, New York, pp 409–430
Laduron PM, Janssen PFM, Leysen JE (1978) Spiperone: a ligand of choice for neuroleptic receptors. Regional distribution and in vivo displacement of neuroleptic drugs. Biochem Pharmacol 27:317–321
Leysen JE, Gommeren W, Laduron PM (1978) Spiperone: a ligand of choice for neuroleptic receptors. Kinetics and characteristics of in vitro binding. Biochem Pharmacol 27:307–316
Morpurgo C, Theobald W (1964) Influence of anti-parkinson drugs and amphetamine on some pharmacological effects of phenothiazine derivatives used as neuroleptics. Psychopharmacologia 6:178–191
Müller P, Seeman P (1974) Neuroleptics: relation between cataleptic and anti-turning actions, and role of the cholinergic system. J Pharm Pharmacol 26:981–984
Schallert T, Whishaw IQ, Ramirez VD, Teitelbaum P (1978a) Compulsive abnormal walking caused by anticholinergics in akinetic 6-hydroxydopamine-treated rats. Science 199:1461–1463
Schallert T, Whishaw IQ, Ramirez VD, Teitelbaum P (1978b) 6-Hydroxydopamine and anticholinergic drugs. Science 202:1215–1217
Shimizu H, Daly JW, Creveling CR (1969) A radioisotopic method for measuring the formation of adenosine 3′,5′-cyclic monophosphate in incubated slices of brain. J Neurochem 16:1609–1619
Singh MM, Kay SR (1979) Therapeutic antagonism between anticholinergic anti-parkinsonism agents and neuroleptics in schizophrenia. Neuropsychobiology 5:74–86
Stephens DN, Herberg LJ (1979) Dopamine-acetylcholine “balance” in nucleus accumbens and corpus striatum and its effect on hypothalamic self-stimulation. Eur J Pharmacol 54:331–339
Thornburg JE, Moore KE (1973a) Dopamine and norepinephrine uptake by rat brain synaptosomes; relative inhibitory potencies of l- and d-amphetamine and amantadine. Res Commun Chem Pathol Pharmacol 5:81–89
Thornburg JD, Moore KE (1973b) Inhibition of anticholinergic drug-induced locomotor stimulation in mice by α-methyltyrosine. Neuropharmacology 12:1179–1185
Watanabe H, Watanabe K, Hagino K (1978) The involvement of catecholamine in scopolamine-induced locomotor activation and rotational behavior in mice. Jpn J Pharmacol 28:465–472
Wauquier A, Niemegeers CJE, Lal H (1975) Differential antagonism by the anticholinergic dexetimide of inhibitory effects of haloperidol and fentanyl on brain self-stimulation. Psychopharmacologia 41:229–235
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ondrusek, M.G., Kilts, C.D., Frye, G.D. et al. Behavioral and biochemical studies of the scopolamine-induced reversal of neuroleptic activity. Psychopharmacology 73, 17–22 (1981). https://doi.org/10.1007/BF00431093
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00431093